In ovarian tumor, CXCL8 promotes the recruitment of tumor associated neutrophils in TME and activates JAG2 in tumor-associated neutrophils, which, in turn, suppresses the activity of the CD8+ T cells (129). Here, CXCL8 is linked to neoplasm.